Pharma
CMS proposes updates to Medicare drug price negotiation program
The agency released draft guidance for the program that includes Part B drugs and price renegotiations.
Pharma
Pharma
Trump signs EO to lower drug prices, industry response is mixed
Pharma companies love the news, but analysts express concern over how it may impact payers and hospitals.
Pharma
Eli Lilly, Novo Nordisk report strong earnings as GLP-1 race heats up
Both drugmakers saw strong YoY sales, though Novo’s GLP-1 sales were down slightly from Q4 2024.
Pharma
What’s next for GLP-1s?
Because who doesn’t prefer swallowing a pill over getting a shot?
Pharma
Novo Nordisk, Hims & Hers partner to sell Wegovy
The telehealth provider has sold compounded versions of Novo’s GLP-1 since 2022.
Pharma
How federal vaccine skepticism could affect public health, pharma industry
“Decades of rigorous global studies involving millions of people have confirmed this science,” one expert said.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
